Chairman of EMA's key drugs evaluation committee resigns unexpectedly
This article was originally published in Scrip
Eric Abadie, chairman of the European Medicines Agency's top human drugs evaluation committee - the CHMP - has unexpectedly resigned from his post. The resignation is reported to be in connection with Dr Abadie's current position at the French medical regulatory authority Afssaps.
You may also be interested in...
After its historic first emergency approval, analysts at Bernstein has upgraded predictions for Pfizer's COVID-19 vaccine in 2021 and beyond.
How UK and EU device regulations will differ in 2021, UK approved bodies and Northern Ireland's unfettered access to the UK market were key themes at the ABHI’s annual regulatory conference.
Regulatory pressure to fully approve the first COVID-19 vaccine in China is mounting as top officials tour an inspection agency and two leading manufacturers.